All Industries

Top Biotech Companies

3,138 Biotech companies, sorted by total funding raised.

GreenLight BioIPO

RNA biotech using a cell-free platform to produce RNA solutions for agriculture, human health, an...

Medford, United States51–200Biotech
Series C·$335.0M·Mar 2025
SC
Science Corporation

Clinical-stage medical technology company developing brain-computer interfaces to restore vision ...

Alameda, United States51–200Biotech, Healthcare
Series C·$334.0M·Mar 2026
Bolt Threads

Biotech company developing sustainable biomaterials including mycelium leather and silk proteins ...

Emeryville11–50Biotech, Climate Tech
Series E·$332.3M·Nov 2024
Compass TherapeuticsIPO

Clinical-stage biotech developing novel antibody-based cancer therapies targeting the tumor micro...

Cambridge, United States11–50Biotech, Healthcare
Venture Unknown·$332.0M·Aug 2025
Varda

In-space pharmaceutical manufacturing company that designs, builds, and flies spacecraft to proce...

El Segundo, United States51–200Biotech, Manufacturing
Series C·$328.0M·Jul 2025
TruepillAcquired

API-connected healthcare infrastructure.

San Mateo, United States1001–5000Digital Health, Healthcare
Series D·$328.0M·Aug 2023
CryoPortIPO

World's largest manufacturer of cryogenic storage systems supporting clinical trials and commerci...

Nashville, United States501–1000healthtech, Biotech
Series C·$326.0M·Feb 2021
Obsidian Therapeutics

Clinical-stage biotech pioneering engineered cell and gene therapies using its proprietary cytoDR...

Cambridge, United States51–200Biotech
Series C·$325.0M·Apr 2024
Synchron

Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware

New York, United States51–200Biotech, Hardware
Series D·$325.0M·Nov 2025
Eat Just

Alternative protein company making plant-based eggs and cultivated meat from animal cells

Alameda, United States201–500Biotech, Food Tech
Venture Unknown·$322.7M·Sep 2023
ADARX Pharmaceuticals

Clinical-stage biotechnology company developing next-generation RNA therapeutics to treat a broad...

United StatesBiotech, Healthcare
Series C·$321.0M·Aug 2023
Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...

Belmont, United States11–50Life Sciences, Biotech
Series B·$321.0M·Nov 2025
Corvus PharmaceuticalsIPO

Clinical-stage biopharmaceutical company focused on developing ITK inhibitor medicines for cancer...

Burlingame, United States11–50healthtech, Biotech
Corporate Round·$319.1M·Jan 2026
Zenas BioPharmaIPO

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...

Boston, United States51–200Biotech, Healthcare
Series C·$318.0M·May 2024
Noema Pharma

Clinical-stage biotech developing oral small molecule therapeutics for debilitating CNS disorders...

Basel, Switzerland11–50Biotech
Extension Round·$318.0M·Dec 2024
Ohalo Genetics

Gene editing for plant breeding to create new crop varieties.

South San Francisco, United States51–200AgriTech, Gene Editing
Series C·$317.3M·Feb 2025
eGenesis

Biotech engineering genetically modified pig organs for human xenotransplantation using CRISPR te...

Cambridge, United States51–200Biotech, Healthcare
Series D·$316.0M·Sep 2024
Bicara TherapeuticsIPO

Clinical-stage biopharma developing dual-action biologics that combine targeted therapy and immun...

Cambridge, United States51–200Biotech, Healthcare
Series C·$313.0M·Dec 2023
CG
Color Genomics

Healthcare company providing population-scale genomics and integrated virtual cancer care for ear...

Burlingame, United States201–500Biotech, Healthcare
Series E·$312.0M·Nov 2021
Neuron23

Clinical-stage biotech developing precision medicines for genetically defined Parkinson’s disease...

South San Francisco, United States11–50Biotech, Drug Discovery
Series D·$310.0M·Jun 2025
ArriVentIPO

Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...

Newtown Square, United States11–50Life Sciences, Biotech
Series B·$305.0M·Mar 2023
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$304.5M·Mar 2025
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Series D·$300.0M·May 2020
Valo Health

AI-enabled biotechnology company using large-scale human data and computation to accelerate drug ...

Boston, United States51–200Artificial Intelligence, Biotech
Series B·$300.0M·Mar 2021
Freenome

AI-powered multiomic liquid biopsies for early cancer detection

South San Francisco, United States501–1000Artificial Intelligence, Healthcare
Series D·$300.0M·Dec 2021